Skip to content

Ultrasound-guided tendon surface injection versus Manipulative therapy and Blind Tender Point Injection for Frozen Shoulder: A Prospective, Multicenter, Randomized Controlled Trial

Ultrasound-guided tendon surface injection versus Manipulative therapy and Blind Tender Point Injection for Frozen Shoulder: A Prospective, Multicenter, Randomized Controlled Trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025874
Enrollment
Unknown
Registered
2019-09-12
Start date
2019-09-10
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

frozen shoulder

Interventions

A Group:Ultrasound-guided tendon surface injection
B group:Manipulative therapy
C group:Blind tender point injection

Sponsors

Southwest Hospital, Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age between 40 to 75 years; 2. Frozen shoulder participants; 3. Visual analogue scale (VAS) for shoulder pain was more than 3 points at rest, or more than 6 points during activity; 4. Shoulder lateral elevation is less than 90 degree; 5. Willing to accept random group treatment and follow-up with research protocol; 6. Voluntary participation in the study and signing of informed consent.

Exclusion criteria

Exclusion criteria: 1. Complete tendon fracture, shoulder dislocation of shoulder joint, or fracture of humeral head proved by ultrasound or other imaging examination and which is not suitable for conservative treatment; 2. Severe heart, lung, liver or kidney disease; 3. Secondary frozen shoulders caused by trauma, cancer, or autoimmune diseases; 4. Allergic to steroids and nonsteroidal drugs; 5. Participants are unable to cooperate, suffering from mental illness, no self-control, unable to express clearly; 6. Skin infections in the pain area of the shoulder; 7. Participants are taking part in other clinical trials; 8. Other situations do not consider suitable for inclusion by researchers.

Design outcomes

Primary

MeasureTime frame
Shoulder Joint Function Evaluation Scale Score;

Secondary

MeasureTime frame
Visual analogue scale;Shoulder Musculoskeletal Ultrasound Assessment Scale;Thickness of shoulder cartilage;Active range of motion;Pain relief;Number of treatments;

Countries

China

Contacts

Public ContactCui Jian

Southwest Hospital, Army Medical University

judy_asdy212@hotmail.com+86 137 5290 2138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 19, 2026